Trial intelligence / Profile preview

Pilot study of oral modafinil in hypercapnic respiratory failure in COPD

2013-005107-13Phase 4Unknown

Sponsor
Epsom and St Helier University Hospitals NHS Trust
Start
Aug 2014
Modality
Small Molecules
Countries
1
01

Overview

Phase 4, single-arm trial of modafinil in chronic obstructive pulmonary disease (COPD) and ventilatory failure (T2RF), sponsored by Epsom and St Helier University Hospitals NHS Trust. Primary endpoint: Improvement in arterial gas abnormalities. Status: unknown.

02

Drugs

modafinil
03

Conditions

chronic obstructive pulmonary disease (COPD)ventilatory failure (T2RF)

Beyond the preview

Go deeper on 2013-005107-13.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2013-005107-13.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call